Foxp4 is dispensable for T cell development, but required for robust recall responses

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Wiehagen, Karla R ^a   Corbo Rodgers, Evann ^a   Li, Shanru ^a   Staub, Elizabeth S ^a   Hunter, Christopher A ^b   Morrisey, Edward E ^a   Maltzman, Jonathan S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR FOXP4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL SURFACE; CYTOKINE PRODUCTION; EFFECTOR CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TOXOPLASMA GONDII; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE DELETION; HOMEOSTASIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYMOCYTES; TOXOPLASMA; UP-REGULATION;

EID: 84865055701     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042273     Document Type: Article

References (37)

1. Carlsson P, Mahlapuu M, (2002) Forkhead transcription factors: key players in development and metabolism. Dev Biol 250: 1-23.
2. Shu W, Yang H, Zhang L, Lu MM, Morrisey EE, (2001) Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J Biol Chem 276: 27488-27497.
3. Kaufmann E, Knochel W, (1996) Five years on the wings of fork head. Mech Dev 57: 3-20.
4. Teufel A, Wong EA, Mukhopadhyay M, Malik N, Westphal H, (2003) FoxP4, a novel forkhead transcription factor. Biochim Biophys Acta 1627: 147-152.
5. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
6. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27.
7. Rudensky AY, (2011) Regulatory T cells and Foxp3. Immunol Rev 241: 260-268.
8. Hu H, Wang B, Borde M, Nardone J, Maika S, et al. (2006) Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol 7: 819-826.
9. Feng X, Ippolito GC, Tian L, Wiehagen K, Oh S, et al. (2010) Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. Blood 115: 510-518.
10. Li S, Weidenfeld J, Morrisey EE, (2004) Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol 24: 809-822.
11. Chokas AL, Trivedi CM, Lu MM, Tucker PW, Li S, et al. (2010) Foxp1/2/4-NuRD interactions regulate gene expression and epithelial injury response in the lung via regulation of interleukin-6. J Biol Chem 285: 13304-13313.
12. Li B, Samanta A, Song X, Iacono KT, Brennan P, et al. (2007) FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int Immunol 19: 825-835.
13. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, et al. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
14. Bettelli E, Dastrange M, Oukka M, (2005) Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 102: 5138-5143.
15. Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, et al. (2007) Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446: 685-689.
16. Du J, Huang C, Zhou B, Ziegler SF, (2008) Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J Immunol 180: 4785-4792.
17. Li B, Samanta A, Song X, Furuuchi K, Iacono KT, et al. (2006) FOXP3 ensembles in T-cell regulation. Immunol Rev 212: 99-113.
18. Li S, Wang Y, Zhang Y, Lu M, Demayo F, et al. (2012) Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2. Development 139: 2500-2509.
19. Liu P, Jenkins NA, Copeland NG, (2003) A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res 13: 476-484.
20. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, et al. (2001) A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763-774.
21. Li S, Zhou D, Lu MM, Morrisey EE, (2004) Advanced cardiac morphogenesis does not require heart tube fusion. Science 305: 1619-1622.
22. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, et al. (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7: 937-945.
23. Sharma SD, Mullenax J, Araujo FG, Erlich HA, Remington JS, (1983) Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol 131: 977-983.
24. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA, (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63-74.
25. Sander B, Hoiden I, Andersson U, Moller E, Abrams JS, (1993) Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods 166: 201-214.
26. Cai G, Kastelein R, Hunter CA, (2000) Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun 68: 6932-6938.
27. Teufel A, Wong EA, Mukhopadhyay M, Malik N, Westphal H, (2003) FoxP4, a novel forkhead transcription factor. Biochimica et Biophysica Acta 1627: 147-152.
28. Feng X, Ippolito GC, Tian L, Wiehagen K, Oh S, et al. (2010) Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. Blood 115: 510-518.
29. Yap GS, Sher A, (1999) Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201: 240-247.
30. Denkers EY, (1999) T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes Infect 1: 699-708.
31. Araujo FG, (1992) Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice. J Immunol 149: 3003-3007.
32. Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A, (1992) Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 149: 175-180.
33. Feng X, Wang H, Takata H, Day TJ, Willen J, et al. (2011) Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat Immunol 12: 544-550.
34. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, et al. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
35. Prilliman KR, Lemmens EE, Palioungas G, Wolfe TG, Allison JP, et al. (2002) Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL. J Immunol 169: 4094-4097.
36. Matloubian M, Concepcion RJ, Ahmed R, (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68: 8056-8063.
37. Casciotti L, Ely KH, Williams ME, Khan IA, (2002) CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells. Infect Immun 70: 434-443.